Canadian Sec - Delayed Quote CAD

Ayr Wellness Inc. (AYR-A.CN)

Compare
1.2700 -0.0100 (-0.78%)
At close: November 8 at 3:59 p.m. EST
Loading Chart for AYR-A.CN
DELL
  • Previous Close 1.2800
  • Open 1.2900
  • Bid 1.2300 x --
  • Ask 1.2700 x --
  • Day's Range 1.2100 - 1.3400
  • 52 Week Range 1.2100 - 5.5000
  • Volume 340,306
  • Avg. Volume 149,238
  • Market Cap (intraday) 144.981M
  • Beta (5Y Monthly) 1.80
  • PE Ratio (TTM) --
  • EPS (TTM) -2.7500
  • Earnings Date Nov 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.44

Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

www.ayrwellness.com

2,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Recent News: AYR-A.CN

View More

Performance Overview: AYR-A.CN

Trailing total returns as of 2024-11-08, which may include dividends or other distributions. Benchmark is

.

YTD Return

AYR-A.CN
47.74%
S&P/TSX Composite index
18.14%

1-Year Return

AYR-A.CN
33.51%
S&P/TSX Composite index
26.48%

3-Year Return

AYR-A.CN
95.01%
S&P/TSX Composite index
15.40%

5-Year Return

AYR-A.CN
89.49%
S&P/TSX Composite index
47.33%

Compare To: AYR-A.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AYR-A.CN

View More

Valuation Measures

As of 2024-11-07
  • Market Cap

    146.12M

  • Enterprise Value

    918.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    0.18

  • Enterprise Value/Revenue

    1.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -41.48%

  • Return on Assets (ttm)

    -0.54%

  • Return on Equity (ttm)

    -33.24%

  • Revenue (ttm)

    464.58M

  • Net Income Avi to Common (ttm)

    -191.06M

  • Diluted EPS (ttm)

    -2.7500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.48M

  • Total Debt/Equity (mrq)

    105.24%

  • Levered Free Cash Flow (ttm)

    -38.26M

Research Analysis: AYR-A.CN

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 117.31M
Earnings -38.76M
Q3'23
Q4'23
Q1'24
Q2'24
-100M
-50M
0
50M
100M
 

Analyst Price Targets

3.00
5.44 Average
1.2700 Current
8.01 High
 

People Also Watch